Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Letter to Our Readers
The Ultimate Target of Personalized Oncology Treatment: Improving the Lives of Our Patients
Mechanism of Action/Pathway Profiles
,
Letter to Our Readers
Read More ›
The Reach of Immunotherapy: Focus on Glioblastoma
By
Sanjiv S. Agarwala, MD
Letter to Our Readers
Read More ›
Enthusiasm Mounts in the Personalized Medicine Movement
Letter to Our Readers
Read More ›
The Evolving Role of Immunotherapeutic Applications in Oncology
By
Sanjiv S. Agarwala, MD
Letter to Our Readers
Read More ›
Reflections on 2014 – Enthusiasm for 2015
By
Al B. Benson III, MD, FACP, FASCO
Letter to Our Readers
Read More ›
Immunotherapy: Early Success in Melanoma Provides Hope for Success in Other Cancers
By
Sanjiv S. Agarwala, MD
Letter to Our Readers
Read More ›
Personalized Medicine in Oncology Proudly Presents the Third Annual World Cutaneous Malignancies Congress and PMO Live: A Global Biomarkers Consortium Initiative
By
Sanjiv S. Agarwala, MD
Letter to Our Readers
Read More ›
PMO: Recognizing the Many Principles Governing the Personalized Medicine Movement
By
Al B. Benson III, MD, FACP, FASCO
Letter to Our Readers
Read More ›
PMO: Advancing the Practitioner’s Ability to Provide Customized Care to Patients
By
Al B. Benson III, MD, FACP, FASCO
Letter to Our Readers
Read More ›
The Evolution of Personalized Medicine in Oncology
By
Sanjiv S. Agarwala, MD
Letter to Our Readers
Read More ›
Page 3 of 4
1
2
3
4